EU medicines agency probes issue with Novartis flu vaccine

LONDON (Reuters) - The European Medicines Agency has started a review into the safety of Novartis's flu vaccine Fluad, following serious adverse events, including deaths, in a small number of elderly Italian patients. The issue is being discussed at a meeting starting on Monday of the agency’s Pharmacovigilance Risk Assessment Committee, which brings together European experts on the safety of medicines. Two batches of the flu vaccine have now been suspended in Italy as a result of the issue, although it is not yet clear whether there is a direct link between the vaccine and the fatalities. ...



via Health News Headlines - Yahoo News http://ift.tt/1vK1BcE